La Fondazione “Diabete Ricerca ONLUS” e la Società Italiana Diabetologia (SID) hanno pubblicato alcuni premi dedicati a progetti di ricerca nell’ambito della patologia sulla quale sono specializzate. I premi sono riservati ai soci SID. La scadenza per la partecipazione è fissata al 20 febbraio 2023.
Fondazione Diabete Ricerca e Società Italiana Diabetologia – Premi di ricerca Leggi tutto »
The Cystic Fibrosis Foundation invites applications for its Biological basis for cystic fibrosis-related diabetes programme. This supports basic research projects that will improve the understanding of the biological basis for the development and progression of cystic fibrosis-related diabetes as well as to identify potential novel therapeutic strategies to manage and treat the disease. US residents
La Fondazione “Diabete Ricerca ONLUS” indice un bando per contribuire alla realizzazione di 2 progetti di ricerca sul diabete mellito riservato a soci SID (da almeno 3 anni) che alla data di scadenza del bando non abbiano compiuto 40 anni. Ogni progetto di ricerca sarà co-finanziato dalla Fondazione con la somma di € 45.000. L’istituzione
The objective of the EFSD/Lilly Young Investigator Research Awards is to encourage innovative research in the fields of diabetes and its complications and to promote excellence in medical education. Applicants should have demonstrated their ability in the field of diabetes research. Research Awards will be made in the sum of Euro 50,000 (fifty thousand) each.
EFSD/Lilly Young Investigator Research Award Programme Leggi tutto »
EUDF and EFSD have established a Digitalisation in Diabetes Care Research Grant to ensure the translation of research into policy actions towards better diabetes care at European and national level. The EFSD/EUDF Research Grant will accept applications in the field of digitalisation in diabetes care. The EFSD/EUDF Digitalisation in Diabetes Care Research Grant is intended
EFSD and EUDF Digitalisation in Diabetes Care Research Grant Leggi tutto »
The objective of the EFSD/DRF/Lilly European Programme in Type 1 Diabetes Research is to encourage new projects aimed at advancing current knowledge in this domain. To achieve the goals and objectives of this Programme, EFSD, JDRF and Lilly invite applications by issuing this “Request for Applications” (RFA), which indicates the areas of research emphasis. Research will
EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research Leggi tutto »
The European Foundation for the Study of Diabetes and the Novo Nordisk Foundation invite applications for their future leaders award programme. This supports clinical and basic scientists in transitioning from postdoctoral clinical fellow to a tenured faculty position in European diabetes research. Applicants must have received their PhD or MD not more than 10 years
EFSD/Novo Nordisk Foundation future leaders award programme 2021 Leggi tutto »
The EFSD European Research Programme on New Targets for Type 2 Diabetes is intended to stimulate and accelerate European research focusing on the identification and molecular understanding of new targets for the treatment of type 2 diabetes. The programme is supported by an educational research grant from MSD. To achieve the goals and objectives of
EFSD – European Research Programme on New Targets for Type 2 Diabetes Leggi tutto »
The objective of the EFSD/DRF/Lilly European Programme in Type 1 Diabetes Research is to encourage new projects aimed at advancing current knowledge in this domain. To achieve the goals and objectives of this Programme, EFSD, JDRF and Lilly invite applications by issuing this “Request for Applications” (RFA), which indicates the areas of research emphasis. Research will
EFSD/JDRF/Lilly European Programme in Type 1 Diabetes Research Leggi tutto »
EFSD has established this independent research programme called the EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges of Diabetes” to encourage projects aimed at advancing current knowledge in the inter-organ crosstalk and related pathophysiology in Diabetes and its complications through innovative basic or clinical research. This EFSD/Boehringer Ingelheim European Diabetes Research Programme is intended to
